Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthma.

MLA

Rhee, Horace, et al. “Airway Tryptase Levels Inform the Lack of Clinical Efficacy of the Tryptase Inhibitor MTPS9579A in Asthma.” Allergy, vol. 79, no. 11, Nov. 2024, pp. 2993–3004. EBSCOhost, https://doi.org/10.1111/all.16309.

APA

Rhee, H., Henderson, L. M., Bauer, R. N., Wong, K., Staton, T. L., Choy, D. F., Banerjee, P., Poon, V., Yoshida, K., Chen, C., Long, K., Sperinde, G., Laing, S. T., Jones, N. S., Glickstein, S. B., Dayal, P., Fong, A., Dash, A., Pulka, G., … Bradding, P. (2024). Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthma. Allergy, 79(11), 2993–3004. https://doi.org/10.1111/all.16309

Chicago

Rhee, Horace, Lindsay M Henderson, Rebecca N Bauer, Kit Wong, Tracy L Staton, David F Choy, Prajna Banerjee, et al. 2024. “Airway Tryptase Levels Inform the Lack of Clinical Efficacy of the Tryptase Inhibitor MTPS9579A in Asthma.” Allergy 79 (11): 2993–3004. doi:10.1111/all.16309.